Hemogenyx Pharmaceuticals PLC New Corporate Video and Investor Webinar

TIDMHEMO

Hemogenyx Pharmaceuticals PLC

06 July 2020

6 July 2020

Hemogenyx Pharmaceuticals plc

("Hemogenyx Pharmaceuticals" or the "Company")

New Corporate Video and Investor Webinar

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, is pleased to announce that a new corporate video is available to view on the Company's website and can be accessed by following the link:

https://youtu.be/LP95GWupyNA

In addition, the Company also announces that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals will host a live investor webinar on 20 July 2020 at 16:00 UK time at which he will answer questions about the Company's current activities. If you would like to register for the webinar, please follow this link:

https://us02web.zoom.us/meeting/register/tZIocuyrqj4pH9HRgZuobXLJdSDkRXUDFRDU

After registering, you will receive a confirmation email containing information about joining the meeting.

Please submit your questions in advance and not later than 17 July 2020 by emailing hemogenyx@hemogenyx.com .

Enquiries:

 
 Hemogenyx Pharmaceuticals plc           www.hemogenyx.com 
 Dr Vladislav Sandler, Chief Executive   headquarters@hemogenyx.com 
  Officer & Co-Founder 
 Peter Redmond, Director 
 
 
 SP Angel Corporate Finance LLP          Tel: +44 (0)20 3470 
                                          0470 
 Matthew Johnson, Vadim Alexandre, 
  Soltan Tagiev 
 
 
 Peterhouse Capital Limited              Tel: +44 (0)20 7469 
                                          0930 
 Lucy Williams, Duncan Vasey, Charles 
  Goodfellow 
 
 
 US Media enquiries                      Tel: +1 (323) 646-3249 
 Lowell Goodman                          lowell@corbomitecomms.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NRARAMBTMTBMTMM

(END) Dow Jones Newswires

July 06, 2020 02:00 ET (06:00 GMT)

Silver Falcon (LSE:SILF)
Historical Stock Chart
From May 2024 to Jun 2024